Skip to main content
Top
Published in: Molecular Neurodegeneration 1/2018

Open Access 01-12-2018 | Commentary

Vibrational spectroscopy: a promising approach to discriminate neurodegenerative disorders

Authors: Maria Paraskevaidi, Pierre L. Martin-Hirsch, Francis L. Martin

Published in: Molecular Neurodegeneration | Issue 1/2018

Login to get access

Abstract

Neurodegenerative diseases are a growing burden in modern society, thus crucially calling for the development of accurate diagnostic strategies. These diseases are currently incurable, a fact which has been attributed to their late diagnosis, after brain damage has already become widespread. An earlier and improved diagnosis is necessary for the enrolment of patients into clinical trials and can pave the way for the development of therapeutic tactics. Novel analytical techniques, such as mass spectrometry and vibrational spectroscopy, have been able to successfully detect and characterise neurodegenerative disorders. It is critical to globally support and make use of innovative basic research and techniques, which could ultimately lead to the creation of a cost-effective diagnostic test. Minimally invasive samples, such as biological fluids, have also been shown to reveal information for these diseases; utilising them could simplify sample collection/analysis and be more preferable to patients.
Literature
1.
go back to reference Martin P, Anders W, Maëlenn G, Gemma-Claire A, Yu-Tzu W, Matthew P. World Alzheimer report 2015: the global impact of dementia: an analysis of prevalence, incidence, cost and trends: Alzheimer's disease international; 2015. Martin P, Anders W, Maëlenn G, Gemma-Claire A, Yu-Tzu W, Matthew P. World Alzheimer report 2015: the global impact of dementia: an analysis of prevalence, incidence, cost and trends: Alzheimer's disease international; 2015.
2.
go back to reference Choo LP, Wetzel DL, Halliday WC, Jackson M, LeVine SM, Mantsch HH. In situ characterization of beta-amyloid in Alzheimer's diseased tissue by synchrotron Fourier transform infrared microspectroscopy. Biophys J. 1996;71:1672–9.CrossRefPubMedPubMedCentral Choo LP, Wetzel DL, Halliday WC, Jackson M, LeVine SM, Mantsch HH. In situ characterization of beta-amyloid in Alzheimer's diseased tissue by synchrotron Fourier transform infrared microspectroscopy. Biophys J. 1996;71:1672–9.CrossRefPubMedPubMedCentral
4.
go back to reference Mapstone M, Cheema AK, Fiandaca MS, Zhong X, Mhyre TR, MacArthur LH, et al. Plasma phospholipids identify antecedent memory impairment in older adults. Nat Med. 2014;20:415–8.CrossRefPubMedPubMedCentral Mapstone M, Cheema AK, Fiandaca MS, Zhong X, Mhyre TR, MacArthur LH, et al. Plasma phospholipids identify antecedent memory impairment in older adults. Nat Med. 2014;20:415–8.CrossRefPubMedPubMedCentral
5.
go back to reference Azria D, Blanquer S, Verdier J-M, Belamie E. Nanoparticles as contrast agents for brain nuclear magnetic resonance imaging in Alzheimer's disease diagnosis. J Mater Chem B. 2017;5:7216–37.CrossRef Azria D, Blanquer S, Verdier J-M, Belamie E. Nanoparticles as contrast agents for brain nuclear magnetic resonance imaging in Alzheimer's disease diagnosis. J Mater Chem B. 2017;5:7216–37.CrossRef
6.
go back to reference Nakamura A, Kaneko N, Villemagne VL, Kato T, Doecke J, Doré V, et al. High performance plasma amyloid-β biomarkers for Alzheimer’s disease. Nature. 2018;554:249.CrossRefPubMed Nakamura A, Kaneko N, Villemagne VL, Kato T, Doecke J, Doré V, et al. High performance plasma amyloid-β biomarkers for Alzheimer’s disease. Nature. 2018;554:249.CrossRefPubMed
7.
go back to reference Nabers A, Ollesch J, Schartner J, Kötting C, Genius J, Hafermann H, et al. Amyloid-β-secondary structure distribution in cerebrospinal fluid and blood measured by an immuno-infrared-sensor: a biomarker candidate for Alzheimer’s disease. Anal Chem. 2016;88:2755–62.CrossRefPubMed Nabers A, Ollesch J, Schartner J, Kötting C, Genius J, Hafermann H, et al. Amyloid-β-secondary structure distribution in cerebrospinal fluid and blood measured by an immuno-infrared-sensor: a biomarker candidate for Alzheimer’s disease. Anal Chem. 2016;88:2755–62.CrossRefPubMed
8.
go back to reference Paraskevaidi M, Morais CLM, Lima KMG, Snowden JS, Saxon JA, Richardson AMT, et al. Differential diagnosis of Alzheimer's disease using spectrochemical analysis of blood. Proc Natl Acad Sci U S A. 2017;114:E7929–e38.CrossRefPubMedPubMedCentral Paraskevaidi M, Morais CLM, Lima KMG, Snowden JS, Saxon JA, Richardson AMT, et al. Differential diagnosis of Alzheimer's disease using spectrochemical analysis of blood. Proc Natl Acad Sci U S A. 2017;114:E7929–e38.CrossRefPubMedPubMedCentral
9.
go back to reference Jermyn M, Mok K, Mercier J, Desroches J, Pichette J, Saint-Arnaud K, et al. Intraoperative brain cancer detection with Raman spectroscopy in humans. Sci Transl Med. 2015;7:274ra19.CrossRefPubMed Jermyn M, Mok K, Mercier J, Desroches J, Pichette J, Saint-Arnaud K, et al. Intraoperative brain cancer detection with Raman spectroscopy in humans. Sci Transl Med. 2015;7:274ra19.CrossRefPubMed
Metadata
Title
Vibrational spectroscopy: a promising approach to discriminate neurodegenerative disorders
Authors
Maria Paraskevaidi
Pierre L. Martin-Hirsch
Francis L. Martin
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Molecular Neurodegeneration / Issue 1/2018
Electronic ISSN: 1750-1326
DOI
https://doi.org/10.1186/s13024-018-0252-x

Other articles of this Issue 1/2018

Molecular Neurodegeneration 1/2018 Go to the issue